Related Experiment Video
Updated: Sep 23, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Symptomatic Myocarditis Post COVID-19 Vaccination
Palak Patel1, Dhaval Desai2,3, Nagapratap Ganta1
1Internal Medicine, Hackensack Meridian Health Ocean University Medical Center, Brick, USA.
Insights
Rarely, coronavirus disease 2019 (COVID-19) vaccines cause major adverse events. Myocarditis and pericarditis are increasingly reported in young people after mRNA COVID-19 vaccines, highlighting the need for early diagnosis and treatment.
Area of Science:
- Cardiology
- Vaccinology
- Public Health
Background:
- The coronavirus disease 2019 (COVID-19) pandemic necessitated rapid vaccine development.
- While generally safe, rare adverse events following immunization require ongoing surveillance.
Observation:
- An increase in myocarditis and pericarditis cases has been reported to the Vaccine Adverse Event Reporting System (VAERS).
- These cases predominantly affect young individuals after receiving messenger RNA (mRNA) COVID-19 vaccines, particularly the second dose.
Findings:
- This case series details myopericarditis following mRNA (Moderna) vaccination and myocarditis post vector-based (Johnson & Johnson) COVID-19 vaccination.
- The findings underscore a potential association between COVID-19 vaccines and inflammatory cardiac conditions.
Implications:
- Early diagnosis and prompt treatment are crucial for managing vaccine-related myocarditis and pericarditis.
- Understanding these adverse events aids in optimizing vaccine safety monitoring and patient care strategies.
Abstract:
There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, increasing cases of myocarditis and pericarditis are being reported to the Vaccine Adverse Event Reporting System (VAERS) in young people, primarily after the second dose of messenger RNA (mRNA) COVID-19 vaccines. We present a case series of myopericarditis post mRNA (Moderna) and myocarditis post vector-based (Johnson & Johnson) COVID-19 vaccines. We intend to highlight the importance of early diagnosis and treatment of vaccine-related myocarditis to reduce mortality and morbidity.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction

